Lipid Profiles in Pediatric Thoracic Transplant Recipients are Determined by Their Immunosuppressive Regimens
- 31 March 2006
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 25 (3) , 276-282
- https://doi.org/10.1016/j.healun.2005.10.006
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatinThe Journal of Heart and Lung Transplantation, 2004
- Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipientsPediatric Transplantation, 2000
- Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipientsPublished by Elsevier ,1999
- National Cholesterol Education Program Recommendations for Cholesterol Testing in Young AdultsCirculation, 1997
- Immunosuppression switch in pediatric heart transplant recipients: Cyclosporine to FK 506Journal of the American College of Cardiology, 1995
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Serum Cholesterol in Young Men and Subsequent Cardiovascular DiseaseNew England Journal of Medicine, 1993
- Hypercholesterolemia after cardiac transplantation in childrenThe American Journal of Cardiology, 1990
- Retransplantation for severe accelerated coronary artery disease in heart transplant recipientsThe American Journal of Cardiology, 1988
- Cholesterol and mortality. 30 years of follow-up from the Framingham studyJAMA, 1987